Predictive factors of 18F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?

被引：0
|
作者：
Alison C. Johnson
Audrey Emmanuelle Dugué
Marlon Silva
Laura Moise
Xavier Tillou
Florence Joly
Nicolas Aide
机构：
[1] François Baclesse Cancer Center,Department of Oncology
[2] François Baclesse Cancer Center,Department of Radiation Therapy
[3] University Hospital of Caen,Department of Urology
[4] University Hospital of Caen,Department of Nuclear Medicine
[5] François Baclesse Cancer Center,Department of Nuclear Medicine
来源：
EJNMMI Research | / 6卷
关键词：
Biochemical recurrence; Radiation therapy; F-choline PET; Prostate cancer; PSA nadir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predictive factors of 18F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?
    Johnson, Alison C.
    Dugue, Audrey Emmanuelle
    Silva, Marlon
    Moise, Laura
    Tillou, Xavier
    Joly, Florence
    Aide, Nicolas
    EJNMMI RESEARCH, 2016, 6
  • [2] Impact of 18F-Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence: Influence of Androgen Deprivation Therapy and Correlation with PSA Kinetics
    Beheshti, Mohsen
    Haim, Silke
    Zakavi, Rasoul
    Steinmair, Martin
    Waldenberger, Peter
    Kunit, Thomas
    Nader, Michael
    Langsteger, Werner
    Loidl, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (06) : 833 - 840
  • [3] 18F-Choline PET/CT in Biochemical Recurrence of Prostate Cancer
    Riola-Parada, C.
    Lucas-Velazquez, B.
    Gomez-Caminero, F.
    Villanueva, J.
    Garcia-Talavera, P.
    Diaz, L.
    Penaherrera, A.
    Canadas Salazar, J.
    Tamayo, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S592 - S592
  • [4] Therapy impact of 18F-PSMA PET/CT in biochemical recurrence of prostate cancer patients with PSA< 1 ng/ml postprostatectomy and 18F-Choline PET/CT negative
    Cozar Santiago, M.
    Garcia Garzon, J.
    Pastor Peiro, J.
    Bassa Massanas, P.
    Canoves Llombart, A.
    Aguilar Barrios, J.
    Sanz Llorens, R.
    Faus Rodrigo, V.
    Soler Lopez, M.
    Ferrer Rebolleda, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S266 - S266
  • [5] EVALUATION OF THE PROGNOSTIC IMPACT OF 18F-CHOLINE PET/CT IN PATIENTS WITH SKELETAL RECURRENCE PROSTATE CANCER
    Zattoni, Fabio
    Evangelista, Laura
    Agostini, Emanuela
    Cattaneo, Francesco
    Guttilla, Andrea
    Zattoni, Filiberto
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1035 - E1035
  • [6] Impact of 18F-choline PET-CT on management of patients with biochemical recurrence of prostate cancer
    Teagle, A. R.
    Robinson, A.
    Nikapota, A.
    McKinna, F.
    Dizdarevic, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S673 - S674
  • [7] Evaluation of the prognostic impact of 18F-Choline PET/CT in patients with skeletal recurrence prostate cancer
    Evangelista, Laura
    Zattoni, Fabio
    Agostini, Emanuela
    Guttilla, Andrea
    Saladini, Giorgio
    Filiberto, Zattoni
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [8] 18F-choline PET/CT detection of prostate cancer recurrence related to PSA level.
    Ptacnik, V.
    Kubinyi, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S367 - S367
  • [9] Role of 18F-Choline PET/CT in detection of prostate cancer recurrence
    Skoura, E.
    Giannopoulou, C.
    Skilakaki, M.
    Bartseas, G.
    Kyprianou, D.
    Datseris, I. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S367 - S367
  • [10] Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
    Jan D. Soyka
    Marco A. Muster
    Daniel T. Schmid
    Burkhardt Seifert
    Ulrike Schick
    Raymond Miralbell
    Sandra Jorcano
    Kathrin Zaugg
    Hans-Helge Seifert
    Patrick Veit-Haibach
    Klaus Strobel
    Niklaus G. Schaefer
    Daniela B. Husarik
    Thomas F. Hany
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 936 - 943
12345